{"id":"imn","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL6","moleculeType":"Small molecule","molecularWeight":"357.79"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"IMN works by activating and enhancing the body's innate and adaptive immune systems to recognize and eliminate malignant cells. The drug is being developed as an immunotherapeutic approach, potentially through toll-like receptor activation or similar innate immune pathways. It is being investigated in combination with other immunotherapies in phase 3 clinical trials.","oneSentence":"IMN is an immunomodulatory agent designed to enhance immune responses against cancer cells.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:15:43.500Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer immunotherapy (specific indication under investigation in phase 3)"}]},"trialDetails":[{"nctId":"NCT07469267","phase":"NA","title":"Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-10-24","conditions":"Breast Cancer, Radiotherapy","enrollment":1608},{"nctId":"NCT04456816","phase":"PHASE2","title":"A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria","status":"RECRUITING","sponsor":"SynAct Pharma Aps","startDate":"2020-08-31","conditions":"Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy","enrollment":23},{"nctId":"NCT02164019","phase":"NA","title":"A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-06","conditions":"Proximal Femoral Metastases","enrollment":73},{"nctId":"NCT07423572","phase":"EARLY_PHASE1","title":"Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Zhejiang Chinese Medical University","startDate":"2026-02-28","conditions":"Refractory Idiopathic Membranous Nephropathy","enrollment":18},{"nctId":"NCT07404436","phase":"PHASE4","title":"Rivaroxaban in Idiopathic Membranous Nephropathy","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-01-05","conditions":"Idiopathic Membranous Nephropathy","enrollment":134},{"nctId":"NCT05766670","phase":"PHASE3","title":"Intramedullary Calcium Sulfate Antibiotic Depot","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-04-08","conditions":"Open tíbia Fracture, Osteomyelitis Tibia, Tibial Fractures","enrollment":497},{"nctId":"NCT04745728","phase":"PHASE3","title":"Different Immunosuppressive Treatment in iMN","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2021-04-14","conditions":"Idiopathic Membranous Nephropathy","enrollment":200},{"nctId":"NCT04743739","phase":"PHASE3","title":"Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN","status":"TERMINATED","sponsor":"Peking Union Medical College Hospital","startDate":"2021-04-14","conditions":"Idiopathic Membranous Nephropathy","enrollment":12},{"nctId":"NCT00930618","phase":"PHASE3","title":"Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-06","conditions":"Prolonged Pregnancy, Nulliparity","enrollment":1409},{"nctId":"NCT06565052","phase":"NA","title":"The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-12-15","conditions":"Rectal Cancer, Colorectal Cancer, Rectal Cancer Stage II","enrollment":40},{"nctId":"NCT07060664","phase":"NA","title":"Study on Outcomes of Proximal Humerus Fractures","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Worcester","startDate":"2026-09-01","conditions":"Proximal Humerus Fracture","enrollment":100},{"nctId":"NCT06976801","phase":"NA","title":"Tibial IMN Vs. Tibial Micromotion IMN","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-07-01","conditions":"Tibial Fracture","enrollment":372},{"nctId":"NCT07121634","phase":"NA","title":"Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Raid M. Al-Ani","startDate":"2024-01-01","conditions":"Cervical Ripening","enrollment":80},{"nctId":"NCT06578403","phase":"NA","title":"Effect of Internal and External Micro-needling in Treatment of Stage III Periodontitis","status":"NOT_YET_RECRUITING","sponsor":"Misr University for Science and Technology","startDate":"2024-12-01","conditions":"Periodontal Diseases","enrollment":66},{"nctId":"NCT03544606","phase":"PHASE4","title":"Nitric Oxide Donor Isosorbide Mono Nitrate for Cervical Ripening in Induction of Labor","status":"COMPLETED","sponsor":"ahmed nagy shaker ramadan","startDate":"2023-12-01","conditions":"Induction of Labor Affected Fetus / Newborn","enrollment":160},{"nctId":"NCT06498375","phase":"","title":"Fluid Status and Body Composition Analysis by Bioelectrical Impedance in Patients After Cardiac Surgery (FLUBIACS)","status":"NOT_YET_RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2024-07","conditions":"Cardiopulmonary Disease, Fluid Overload","enrollment":150},{"nctId":"NCT06436365","phase":"NA","title":"Is the Expert Nail With Poller Screws Superior to the Distal Tibial Locked Plate in the Management of Short Oblique Distal Tibial Fractures?","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2023-02-01","conditions":"Tibia Fracture","enrollment":42},{"nctId":"NCT06280417","phase":"","title":"Unreamed Intramedullary Tibial Nailing in Treatment of Open IIIa Diaphyseal Tibial Fractures in Adults","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-06-01","conditions":"Tibia Fracture","enrollment":25},{"nctId":"NCT05850845","phase":"","title":"Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMN","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2023-06-25","conditions":"Hyperspectral Imaging, Idiopathic Membranous Nephropathy, Cyclophosphamide","enrollment":40},{"nctId":"NCT05568316","phase":"NA","title":"Impact of Immunonutrition on Nutritional Status in Colorectal Cancer Patients","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2020-11-01","conditions":"Colorectal Cancer","enrollment":50},{"nctId":"NCT05797038","phase":"","title":"Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2023-04-25","conditions":"Idiopathic Membranous Nephropathy, Tacrolimus, Hyperspectral Imaging","enrollment":40},{"nctId":"NCT05691179","phase":"","title":"COVID-19 Infection and Idiopathic Membranous Nephropathy","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2022-12-10","conditions":"Idiopathic Membranous Nephropathy","enrollment":130},{"nctId":"NCT04472845","phase":"NA","title":"HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2021-03-30","conditions":"Breast Cancer, Hypofractionation, Radiotherapy Side Effect","enrollment":1018},{"nctId":"NCT03861624","phase":"NA","title":"Intramedullary Nailing Versus External Fixation in Open Tibia Fractures in Tanzania","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-12-17","conditions":"Tibial Fractures, Open Fracture of Tibia, Trauma","enrollment":240},{"nctId":"NCT05341856","phase":"EARLY_PHASE1","title":"Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL","status":"UNKNOWN","sponsor":"Al-Azhar University","startDate":"2022-05-01","conditions":"Recurrent Pregnancy Loss","enrollment":60},{"nctId":"NCT03466801","phase":"NA","title":"The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.","status":"TERMINATED","sponsor":"Wenhu Liu","startDate":"2018-03-20","conditions":"Idiopathic Membranous Nephropathy","enrollment":6},{"nctId":"NCT03171480","phase":"PHASE4","title":"Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2017-10-30","conditions":"Preeclampsia, Labor, Premature","enrollment":176},{"nctId":"NCT01508468","phase":"PHASE3","title":"Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-01-17","conditions":"Idiopathic Membranous Nephropathy","enrollment":80},{"nctId":"NCT05059379","phase":"PHASE3","title":"Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2021-09-20","conditions":"Breast Cancer, Radiotherapy; Complications, Effect of Radiation Therapy","enrollment":1650},{"nctId":"NCT04127045","phase":"","title":"ProspEctive Cohort Study on Multidisciplinary Approach to Femur FRactures' manAgement in Over 65 Population","status":"COMPLETED","sponsor":"Biagio Moretti, MD","startDate":"2017-10-02","conditions":"Hip Fractures, Intertrochanteric Fractures, Femur Fracture","enrollment":20},{"nctId":"NCT04195334","phase":"NA","title":"IMN Diameter to Femoral Canal Diameter and Union","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-01-01","conditions":"Femoral Shaft Fracture","enrollment":100},{"nctId":"NCT03126448","phase":"NA","title":"BBOT: Bacterial Burden in Ortho Trauma Procedures","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2015-12-21","conditions":"Orthopaedic Trauma Infections","enrollment":142},{"nctId":"NCT01386554","phase":"PHASE4","title":"Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2011-08","conditions":"Proteinuria, Idiopathic Membranous Nephropathy","enrollment":60},{"nctId":"NCT01180036","phase":"PHASE2, PHASE3","title":"MEmbranous Nephropathy Trial Of Rituximab","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-11","conditions":"Idiopathic Membranous Nephropathy","enrollment":130},{"nctId":"NCT03549663","phase":"NA","title":"Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2018-07-04","conditions":"Idiopathic Membranous Nephropathy","enrollment":108},{"nctId":"NCT02418260","phase":"PHASE3","title":"Surgical Interventions for the Treatment of Humeral Shaft Fractures","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2014-06","conditions":"Fracture of Shaft of Humerus, Humerus Fracture","enrollment":120},{"nctId":"NCT01133769","phase":"","title":"Operative Versus Non-Operative Treatment of Clavicle Fracture in PolyTrauma","status":"WITHDRAWN","sponsor":"Anna Rockich","startDate":"2010-06","conditions":"Clavicle Fracture, Chest Injury","enrollment":""},{"nctId":"NCT01042132","phase":"NA","title":"Intramedullary Femoral Reaming, Human Study","status":"COMPLETED","sponsor":"Ullevaal University Hospital","startDate":"2003-05","conditions":"Pulmonary Complications, Organ Failure, Systemic Inflammatory Response Syndrome","enrollment":17},{"nctId":"NCT02712125","phase":"PHASE2, PHASE3","title":"Nitric Oxide Donors for Treatment of Isolated Oligohydramnios","status":"COMPLETED","sponsor":"Benha University","startDate":"2013-08","conditions":"Isolated (Idiopathic) Oligohydramnios","enrollment":100},{"nctId":"NCT01506388","phase":"PHASE3","title":"A Novel Protocol for Labour Induction","status":"COMPLETED","sponsor":"Cairo University","startDate":"2012-02","conditions":"Failed Induction of Labor","enrollment":400},{"nctId":"NCT00299052","phase":"PHASE4","title":"Efficacy of DBM on Fractures of the Shinbone (Tibia)","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-03","conditions":"Closed Fracture, Open Fracture","enrollment":16},{"nctId":"NCT00686023","phase":"NA","title":"Comparing Surgical Techniques for CRIF of Pertrochanteric Fractures","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2008-06","conditions":"Femur Fracture","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1964,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IMN","genericName":"IMN","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IMN is an immunomodulatory agent designed to enhance immune responses against cancer cells. Used for Cancer immunotherapy (specific indication under investigation in phase 3).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}